IC for customizable, modular bioprocess solutions

With a successful demonstration of a proof-of-concept device at Knowledge for Growth (#KFG2023) before the summer holiday period, BioDevice-CRO is gaining momentum. Antleron Co-Development Architect, Filip Donvil, and ICsense CEO Bram de Muer, were interviewed by BioVox, for the MEDVIA article series, to talk about the motivations and vision behind the collaborative project and offering.

You can read the full article here -> https://lnkd.in/ePACuaRn

The BioDevice-CRO partnership, powered by MEDVIA, provides actors with customizable, modular bioprocess solutions. Combining the multidisciplinary expertise of Antleron, Comate, and ICsense brings a unique offering to life science organizations.

Links to the eco-system:

More news articles

ICsense at Electronica 2026 (booth C4.100)

Read more

ICsense reports 30% revenue growth as demand for independent custom IC supply accelerates

Read more

ICsense announces participation in IMPHORIA EU project

Read more